subject: UMLS:C1327844

object_name: anus cancer


subject: UMLS:C1327844

object_name: anal carcinoma

tested_intervention: yes


subject: UNII:E3B2GI648A

subject_name: Belatacept

object_name: nephrotoxicity


subject: CHEBI:93775

subject_name: Amethopterin

object_name: Erythema nodosum leprosum

tested_intervention: unsure


subject: CHEBI:93775

object_name: Type 2 lepra reaction


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:231356

subject_name: Varlitinib

object_name: Childhood Solid Neoplasm


subject: CHEBI:231356

object_name: Adult Solid Neoplasm


subject: UMLS:C4732973


subject: UMLS:C4732973


subject: CHEBI:29287

subject_name: Gold


subject: CHEBI:29287


subject: CHEBI:29287

object_name: Solid Neoplasm


subject: CHEBI:9434

subject_name: Telmisartan

object_name: proteinuria


subject: CHEBI:9434

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:9434

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:9434

object_name: Proteinuria, CTCAE 5.0


subject: CHEBI:9434

object_name: chronic kidney disease


subject: CHEBI:9434

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C5203466

subject_name: Zoledronic Acid Liquid Injection

object_name: Anterior Cruciate Ligament Tear


subject: UMLS:C5203466

object_name: Anterior Cruciate Ligament Injuries


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: UMLS:C4053626

subject_name: LAG 525

object_name: triple-negative breast carcinoma


subject: UMLS:C4053626

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:73727

object_name: liver carcinoma


subject: CHEBI:49956

subject_name: Xenon

object_name: respiratory system disorder


subject: CHEBI:9123

subject_name: Sertraline

object_name: Pruritus, CTCAE


subject: CHEBI:9123

object_name: Pruritus


subject: CHEBI:9123

object_name: primary biliary cholangitis


subject: MESH:D000084922

subject_name: Resistant Starch

object_name: type 2 diabetes mellitus


subject: MESH:D000084922

object_name: Insulin resistance


subject: UNII:EEM82VOY7C

subject_name: chlorophyllin

object_name: Diffuse Glioma


subject: UNII:EEM82VOY7C

object_name: Necrosis of brain caused by ionizing radiation


subject: UNII:EEM82VOY7C

object_name: High grade glioma


subject: UNII:EEM82VOY7C

object_name: malignant glioma


subject: UNII:EEM82VOY7C

object_name: glioblastoma


subject: UNII:EEM82VOY7C

object_name: Brain Stem Glioblastoma


subject: UNII:EEM82VOY7C

object_name: glioma susceptibility 1


subject: CHEBI:6456

subject_name: Lidocaine

object_name: vulvar disease


subject: CHEBI:74051

subject_name: His-His

object_name: Postoperative Hemorrhage, CTCAE


subject: CHEBI:74051

object_name: Postoperative Hemorrhage


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: congestive heart failure


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:3770

subject_name: co-trimoxazole

object_name: ventilator-associated pneumonia


subject: UMLS:C0041044


subject: CHEBI:16374

subject_name: Menatetrenone

object_name: liver carcinoma


subject: UNII:072702W9QD

object_name: cancer


subject: UNII:072702W9QD

object_name: neoplasm


subject: UMLS:C3491576


subject: UMLS:C3491576


subject: CHEBI:60654

subject_name: valproate

object_name: migraine


subject: CHEBI:60654

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:168243

subject_name: Valproic acid glucuronide


subject: UMLS:C1875441

subject_name: lidocaine / sodium chloride

object_name: peripheral nervous system disorder


subject: UMLS:C1875441

object_name: neuropathy


subject: UMLS:C1875441

object_name: Childhood Breast Carcinoma


subject: UMLS:C1875441

object_name: breast carcinoma


subject: UMLS:C1875441

object_name: breast cancer


subject: UMLS:C1875441

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: UNII:KNM216XOUH

object_name: pervasive developmental disorder


subject: UNII:KNM216XOUH

object_name: autism


subject: UNII:KNM216XOUH

object_name: autism spectrum disorder


subject: UMLS:C3500879


subject: UMLS:C3500879


subject: UMLS:C3500879


subject: CHEBI:188986

subject_name: idose

object_name: low tension glaucoma


subject: UMLS:C3181263

subject_name: CDX 110

object_name: malignant glioma


subject: UMLS:C1611967

object_name: stroke disorder


subject: UMLS:C1611967

object_name: cerebrovascular disorder


subject: UMLS:C1611967

object_name: Stroke (heart beat)


subject: UMLS:C1611967

object_name: Stroke, CTCAE


subject: CHEBI:6532

subject_name: Loperamide

object_name: non-small cell lung carcinoma


subject: CHEBI:132922

object_name: glaucoma


subject: CHEBI:132922

object_name: Glaucoma, CTCAE


subject: CHEBI:132922

object_name: ocular hypertension


subject: CHEBI:132922

object_name: Ocular hypertension


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:231425

subject_name: tolvaptan

object_name: Dilutional hyponatremia


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Moderate asthma


subject: CHEBI:5296

subject_name: Gemfibrozil

object_name: cancer


subject: CHEBI:5296

object_name: neoplasm


subject: PUBCHEM.COMPOUND:135405876

subject_name: Folate

object_name: Androgen excess


subject: PUBCHEM.COMPOUND:135405876

object_name: anovulation


subject: PUBCHEM.COMPOUND:135405876

object_name: Female infertility associated with anovulation


subject: CHEBI:62501


subject: CHEBI:62501


subject: CHEBI:62501


subject: CHEBI:37445

subject_name: folic acids


subject: CHEBI:37445


subject: CHEBI:37445


subject: UMLS:C0178638

subject_name: folate


subject: UMLS:C0178638


subject: UMLS:C0178638


subject: CHEBI:67011

subject_name: folates


subject: CHEBI:67011


subject: CHEBI:67011


subject: CHEBI:27470

subject_name: Folic acid


subject: CHEBI:27470


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: severe combined immunodeficiency


subject: CHEBI:201431

object_name: immune system disorder


subject: CHEBI:201431

object_name: T-B+ severe combined immunodeficiency due to gamma chain deficiency


subject: CHEBI:201431

object_name: Severe Combined Immunodeficiency with Absence of T and B Cells


subject: CHEBI:201431

object_name: severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency


subject: CHEBI:201431

object_name: Autosomal Recessive Disorder


subject: CHEBI:201431

object_name: purine nucleoside phosphorylase deficiency


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: UMLS:C5206716

object_name: skin squamous cell carcinoma


subject: UMLS:C5206716

object_name: melanoma


subject: CHEBI:177298

object_name: Cervix carcinoma recurrent


subject: CHEBI:176844

subject_name: Niraparib


subject: PUBCHEM.COMPOUND:44427043

subject_name: SULPHADOXINE

object_name: malaria


subject: UNII:CVN0S9V910

subject_name: MAL

object_name: acne


subject: CHEBI:15595


subject: CHEBI:231614

subject_name: Nivolumab

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C2346820


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Refractory AL Amyloidosis


subject: CHEBI:72690

subject_name: Pomalidomide

object_name: Amyloid deposition


subject: CHEBI:72690


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Locally advanced breast cancer


subject: UMLS:C2346810

object_name: urothelial carcinoma


subject: UMLS:C2346810

object_name: transitional cell carcinoma


subject: UMLS:C2346810

object_name: ureter cancer


subject: UMLS:C2346810

object_name: ureter carcinoma


subject: UMLS:C2346810

object_name: ureter neoplasm


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: Tabagism


subject: CHEBI:84040

object_name: mood (physical finding)


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: UMLS:C1101322

subject_name: trans-Resveratrol


subject: CHEBI:27881

subject_name: resveratrol


subject: UNII:6029HGL0QP

subject_name: fluorocholine

object_name: Localized Resectable Adult Liver Carcinoma


subject: UNII:6029HGL0QP

object_name: adult hepatocellular carcinoma


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type


subject: CHEBI:91397

object_name: Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type


subject: GTOPDB:9802

object_name: type 1 diabetes mellitus 1


subject: GTOPDB:9802

object_name: type 1 diabetes mellitus


subject: UMLS:C4548814


subject: UMLS:C4548814


subject: MESH:C000634149

object_name: Advanced breast cancer


subject: UMLS:C5455405

subject_name: Ryplazim

object_name: hypoplasminogenemia


subject: UMLS:C5455405

object_name: Decreased level of plasminogen


subject: CHEBI:4672

subject_name: Docetaxel

object_name: metastatic colorectal cancer


subject: CHEBI:4672

object_name: adenoid cystic carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: Advanced Malignant Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: small cell lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: non-small cell lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: metastatic melanoma


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: Carcinoma breast stage IV


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: metastatic prostate carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: Metastatic Renal Cell Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: Metastatic Renal Cell Cancer


subject: CHEMBL.COMPOUND:CHEMBL4594486


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: Head and neck cancer metastatic


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: Stomach cancer


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: gastric cancer


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: pancreatic neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: exocrine pancreatic carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: malignant pancreatic neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: cervical cancer


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: cervical carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: carcinoma of esophagus


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: esophageal cancer


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: Childhood Esophageal Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: neoplasm of esophagus


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: salivary gland carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: salivary gland cancer


subject: CHEMBL.COMPOUND:CHEMBL4594486


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: adrenal cortex carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: adenoid cystic carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: urothelial carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: transitional cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: malignant soft tissue neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: sarcoma


subject: UMLS:C5417995

subject_name: Gotistobart

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5417995

object_name: small cell lung carcinoma


subject: UMLS:C5417995

object_name: metastatic melanoma


subject: UMLS:C5417995

object_name: Carcinoma breast stage IV


subject: UMLS:C5417995

object_name: metastatic prostate carcinoma


subject: UMLS:C5417995

object_name: Metastatic Renal Cell Carcinoma


subject: UMLS:C5417995

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C5417995

object_name: metastatic colorectal cancer


subject: UMLS:C5417995

object_name: Head and neck cancer metastatic


subject: UMLS:C5417995

object_name: Stomach cancer


subject: UMLS:C5417995

object_name: gastric cancer


subject: UMLS:C5417995

object_name: pancreatic neoplasm


subject: UMLS:C5417995

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5417995

object_name: malignant pancreatic neoplasm


subject: UMLS:C5417995

object_name: cervical cancer


subject: UMLS:C5417995

object_name: cervical carcinoma


subject: UMLS:C5417995

object_name: carcinoma of esophagus


subject: UMLS:C5417995

object_name: esophageal cancer


subject: UMLS:C5417995

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5417995

object_name: neoplasm of esophagus


subject: UMLS:C5417995

object_name: salivary gland carcinoma


subject: UMLS:C5417995

object_name: salivary gland cancer


subject: UMLS:C5417995


subject: UMLS:C5417995

object_name: adrenal cortex carcinoma


subject: UMLS:C5417995

object_name: adenoid cystic carcinoma


subject: UMLS:C5417995

object_name: urothelial carcinoma


subject: UMLS:C5417995

object_name: transitional cell carcinoma


subject: UMLS:C5417995

object_name: malignant soft tissue neoplasm


subject: UMLS:C5417995

object_name: sarcoma


subject: UNII:3765U8A1EC

subject_name: Nolasiban

object_name: Premature Labor


subject: CHEBI:8871

subject_name: Risperidone

object_name: chorea


subject: CHEBI:119486

subject_name: Efavirenz

object_name: sleep disorder


subject: CHEBI:63589

subject_name: Etravirine


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Headache


subject: CHEBI:6888

object_name: Headache, CTCAE


subject: CHEBI:6888

object_name: traumatic encephalopathy


subject: CHEBI:2904

subject_name: Atenolol

object_name: Intraoperative Hemorrhage


subject: UNII:C8ADC441ME

subject_name: Ivabradine


subject: CHEBI:8499

subject_name: Propranolol


subject: UMLS:C2698898

subject_name: Prostate Health Cocktail Dietary Supplement

object_name: prostate carcinoma


subject: UMLS:C2698898

object_name: prostate cancer


subject: UNII:082285VIDF

subject_name: fluoromisonidazole

object_name: head and neck squamous cell carcinoma


subject: UNII:082285VIDF

object_name: metastatic malignant neoplasm in the brain


subject: UNII:8MSY49469G

subject_name: Fluoromisonidazole F-18


subject: CHEBI:6532

subject_name: Loperamide

object_name: triple-negative breast carcinoma


subject: CHEBI:6532

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5556351

object_name: biliary tract cancer


subject: UMLS:C5556351

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C5556351

object_name: liver carcinoma


subject: CHEBI:8988

object_name: Gastroesophageal junction cancer


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:131168

subject_name: Afuresertib

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C4547386

object_name: narcolepsy


subject: CHEBI:37924

subject_name: Atazanavir

object_name: tuberculosis


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin

object_name: influenza


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: UNII:DFC121MXC3

subject_name: Pimodivir


subject: UMLS:C4764355


subject: CHEBI:6931

subject_name: Midazolam


subject: PUBCHEM.COMPOUND:70105374

subject_name: Pitavastatin Lactone


subject: CHEBI:32020

subject_name: Pitavastatin


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: severe acute respiratory syndrome


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C1527137

subject_name: Recombinant melatonin


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Acute disease of musculoskeletal system


subject: CHEBI:6456

object_name: Emergencies


subject: CHEBI:6456

object_name: Sprains and Strains


subject: CHEBI:6456

object_name: Sprain


subject: CHEBI:6456

object_name: urologic injuries


subject: CHEBI:6456

object_name: Male Genital Injuries


subject: CHEBI:6456

object_name: Female genital injuries


subject: CHEBI:6456

object_name: Physical trauma


subject: CHEBI:6456

object_name: Trauma


subject: PUBCHEM.COMPOUND:152165

object_name: infertility


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:31547

subject_name: Eplerenone

object_name: systolic heart failure


subject: CHEBI:9241

subject_name: Spironolactone


subject: UMLS:C0591463

subject_name: Zemuron

object_name: no feeling or sensation of skin


subject: UMLS:C0591463

object_name: Sensory Loss


subject: CHEBI:144094

subject_name: bicalutamide

object_name: Castration-Sensitive Prostate Carcinoma


subject: CHEBI:144094

object_name: Stage IVB Prostate Cancer AJCC v8


subject: CHEBI:144094

object_name: Adenocarcinoma of the prostate metastatic


subject: PUBCHEM.COMPOUND:44151801

subject_name: Degarelix


subject: PUBCHEM.COMPOUND:44151801


subject: PUBCHEM.COMPOUND:44151801

object_name: Stage IVA Prostate Cancer AJCC v8


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: CHEBI:5523

subject_name: Goserelin


subject: CHEBI:5523


subject: CHEBI:5523


subject: CHEBI:5523


subject: UMLS:C0149473

subject_name: Zoladex


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: CHEBI:6427

subject_name: Leuprolide


subject: GTOPDB:8313

subject_name: talazoparib


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: CHEBI:6801

subject_name: Metformin

object_name: Duchenne muscular dystrophy


subject: CHEBI:3223

subject_name: Buspirone

object_name: traumatic brain injury


subject: CHEBI:8871

subject_name: Risperidone


subject: CHEBI:63610

subject_name: Misoprostol

object_name: lumbar spinal stenosis


subject: CHEBI:63610

object_name: spinal stenosis


subject: CHEBI:63610

object_name: Low back pain


subject: UMLS:C3639092

subject_name: HPV E1/E2 Interaction Inhibitor Gel AP611074

object_name: Genital warts


subject: UMLS:C3639092

object_name: human papilloma virus infection


subject: UMLS:C3639092

object_name: Condylomata acuminata in women


subject: UMLS:C3639092

object_name: Condylomata acuminata in men


subject: CHEBI:9635

subject_name: Toremifene

object_name: breast neoplasm


subject: PUBCHEM.COMPOUND:4739

subject_name: Vidarbine

object_name: mantle cell lymphoma


subject: PUBCHEM.COMPOUND:4739

object_name: marginal zone lymphoma


subject: PUBCHEM.COMPOUND:4739

object_name: MALT lymphoma


subject: PUBCHEM.COMPOUND:4739

object_name: follicular lymphoma


subject: CHEBI:27834

subject_name: Pentostatin


subject: CHEBI:27834


subject: CHEBI:27834


subject: CHEBI:27834


subject: UMLS:C0057002

subject_name: cytomegalovirus immune globulin

object_name: cytomegalovirus infection


subject: UMLS:C4310002

object_name: Hepatic impairment


subject: UMLS:C4310001


subject: CHEBI:31355

subject_name: Carboplatin

object_name: childhood germ cell brain tumor


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:5864

subject_name: Ifosfamide


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: atopic eczema


subject: UMLS:C0295415

subject_name: rituximab


subject: PUBCHEM.COMPOUND:2767

object_name: survival time


subject: CHEBI:175901

subject_name: Gemcitabine


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1135137

object_name: pancreatic neoplasm


subject: UMLS:C1135137

object_name: exocrine pancreatic carcinoma


subject: UMLS:C1135137

object_name: malignant pancreatic neoplasm


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: Presenile dementia


subject: CHEBI:70746

object_name: dementia


subject: CHEBI:70746

object_name: cognitive disorder


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:70752


subject: CHEBI:70752


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Neonatal hypoxic and ischemic brain injury


subject: UMLS:C1527137

object_name: cell injury


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: congenital alveolar dysplasia


subject: UNII:1C6V77QF41

object_name: respiratory distress syndrome in premature infants


subject: UNII:1C6V77QF41

object_name: adult acute respiratory distress syndrome


subject: UNII:1C6V77QF41

object_name: newborn respiratory distress syndrome


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: brain injury


subject: UNII:PVI5M0M1GW

object_name: Parkinson disease


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: CHEBI:15379

subject_name: Oxygen

object_name: Atelectasis


subject: CHEBI:15379

object_name: Atelectasis, CTCAE


subject: CHEBI:31859

subject_name: Modafinil

object_name: Critical Illness


subject: CHEBI:31859


subject: UMLS:C0308804

subject_name: Dexamethasone Sodium Phosphate Injection

object_name: Irreversible pulpitis


subject: UMLS:C3641717

subject_name: SUBA-itraconazole

object_name: tinea unguium


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: hypospadias


subject: UMLS:C4086546

object_name: Penile hypospadias


subject: CHEBI:95165

object_name: stage IVC papillary thyroid cancer


subject: CHEBI:95165

object_name: stage IVA follicular thyroid cancer


subject: CHEBI:95165

object_name: stage IVC follicular thyroid cancer


subject: CHEBI:95165

object_name: stage IVB follicular thyroid cancer


subject: CHEBI:95165

object_name: stage IVA papillary thyroid cancer


subject: CHEBI:95165

object_name: stage IVB papillary thyroid cancer


subject: CHEBI:95165

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:81567

subject_name: Thyrotropin


subject: CHEBI:81567


subject: CHEBI:81567


subject: CHEBI:81567


subject: CHEBI:81567


subject: CHEBI:81567


subject: CHEBI:81567


subject: UMLS:C0876183

subject_name: Thyrogen


subject: UMLS:C0876183


subject: UMLS:C0876183


subject: UMLS:C0876183


subject: UMLS:C0876183


subject: UMLS:C0876183


subject: UMLS:C0876183


subject: UNII:25CG88L0BB

subject_name: Brensocatib

object_name: kidney failure


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: staphylococcal infection


subject: DRUGBANK:DB16596

subject_name: Apple cider vinegar

object_name: Depressed mood


subject: DRUGBANK:DB16596

object_name: Cancer patients and suicide and depression


subject: DRUGBANK:DB16596

object_name: Depressed - symptom


subject: DRUGBANK:DB16596

object_name: Depression, CTCAE


subject: DRUGBANK:DB16596

object_name: mood (physical finding)


subject: PUBCHEM.COMPOUND:44247724

object_name: essential hypertension


subject: UMLS:C3886750


subject: MESH:C418997

subject_name: lyprinol

object_name: Bronchospasm, Exercise-Induced


subject: MESH:C418997

object_name: exercise-induced bronchoconstriction


subject: MESH:C418997

object_name: asthma


subject: CHEBI:7421

subject_name: NAC

object_name: familial Dupuytren contracture


subject: CHEBI:7421

object_name: palmar fibromatosis


subject: CHEBI:7421

object_name: Peroneal Nerve Entrapment


subject: CHEBI:7421

object_name: de Quervain syndrome


subject: CHEBI:7421

object_name: trigger thumb


subject: CHEBI:7421

object_name: tarsal tunnel syndrome


subject: CHEBI:7421

object_name: Morton neuroma


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:44423

subject_name: Hydroxyurea

object_name: carcinoma of esophagus


subject: CHEBI:44423

object_name: esophageal cancer


subject: CHEBI:44423

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:44423

object_name: neoplasm of esophagus


subject: CHEBI:1391

subject_name: Midomafetamine

object_name: binge eating


subject: CHEBI:1391

object_name: Anorexia nervosa, restricting type


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Anesthetics adverse reaction


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: Caesarean section


subject: UNII:X00B0D5O0E

subject_name: PIPERACILLIN

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:X00B0D5O0E

object_name: obesity


subject: UNII:X00B0D5O0E

object_name: Obesity, CTCAE


subject: CHEBI:8232

subject_name: Piperacillin


subject: CHEBI:8232


subject: CHEBI:8232


subject: CHEBI:6504

object_name: Frontotemporal dementia (FTD)


subject: PUBCHEM.COMPOUND:73417116

subject_name: TRANYLCYPROMINE

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:73417116

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:73417116

object_name: Adult Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:73417116

object_name: childhood myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:73417116

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:182949

subject_name: Tranylcypromine


subject: CHEBI:182949


subject: CHEBI:182949


subject: CHEBI:182949


subject: CHEBI:182949


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: Androgen excess


subject: UNII:19FUJ2C58T

subject_name: Ginkgo biloba

object_name: open-angle glaucoma


subject: UMLS:C3531686

subject_name: Ginkgo biloba whole extract


subject: UMLS:C5667008

subject_name: CCR8 Inhibitor IPG7236

object_name: Safety Issues


subject: CHEBI:18053

subject_name: 1-Aminocyclopropanecarboxylic Acid

object_name: proteinuria


subject: CHEBI:18053

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:18053

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:18053

object_name: Proteinuria, CTCAE 5.0


subject: CHEBI:18053

object_name: chronic kidney disease


subject: CHEBI:18053

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:30526


subject: CHEBI:30526


subject: CHEBI:30526


subject: CHEBI:30526


subject: CHEBI:30526


subject: CHEBI:30526


subject: UMLS:C4763665

object_name: neoplasm


subject: PUBCHEM.COMPOUND:11332179

subject_name: pasireotide

object_name: angiodysplasia


subject: CHEBI:50005

subject_name: trans-stilbene oxide

object_name: food allergy


subject: CHEBI:3176

subject_name: Brinzolamide

object_name: Posterior capsule opacification


subject: PUBCHEM.COMPOUND:71300725

subject_name: Etirinotecan pegol

object_name: Non-small cell lung cancer recurrent


subject: PUBCHEM.COMPOUND:71300725

object_name: Metastatic non-small cell lung cancer


subject: UNII:LJ16641SFT


subject: UNII:LJ16641SFT


subject: UMLS:C2830036


subject: UMLS:C2830036


subject: UMLS:C0534628

subject_name: Endostatins

object_name: Recurrent Childhood Glioblastoma


subject: UMLS:C0534628

object_name: Recurrent Glioblastoma


subject: UMLS:C1705207

subject_name: Endostar


subject: UMLS:C1705207


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: IDH1 gene mutation


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:6801

subject_name: Metformin

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:6801

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C3814375

subject_name: Argemone mexicana extract

object_name: malaria


subject: UMLS:C5399992

object_name: Recurrent Myelodysplastic Syndrome


subject: UMLS:C5399992

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: UMLS:C5399992

object_name: Refractory Myelodysplastic Syndrome


subject: UMLS:C5399992

object_name: Blasts More than 10 Percent of Bone Marrow Nucleated Cells


subject: CHEBI:90217

subject_name: Quizartinib


subject: UNII:U2I8T43Y7R

subject_name: axicabtagene ciloleucel

object_name: Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: UNII:U2I8T43Y7R

object_name: Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: DRUGBANK:DB18628

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:60654

subject_name: valproate

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:168243

subject_name: Valproic acid glucuronide


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: juvenile idiopathic arthritis


subject: UMLS:C0962969

subject_name: RAD 001

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: UMLS:C0962969

object_name: primary cutaneous T-cell lymphoma


subject: UMLS:C0962969

object_name: ALK-negative anaplastic large cell lymphoma


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: UNII:CWG62Q1VTB

subject_name: Sitravatinib

object_name: melanoma


subject: DRUGBANK:DB16541

subject_name: Lactobacillus casei

object_name: Colonic diverticula


subject: CHEBI:83629

subject_name: tea tree oil

object_name: blepharitis


subject: DRUGBANK:DB11218

subject_name: Tea tree oil


subject: CHEMBL.COMPOUND:CHEMBL3544945

object_name: osteoarthritis


subject: UMLS:C4329340

subject_name: Nisevokitug

object_name: adult hepatocellular carcinoma


subject: UMLS:C4329340

object_name: liver cancer


subject: UMLS:C4329340

object_name: pediatric hepatocellular carcinoma


subject: UMLS:C4329340

object_name: liver carcinoma


subject: UMLS:C4329340

object_name: colorectal cancer


subject: UMLS:C4329340

object_name: colorectal carcinoma


subject: UMLS:C4329340

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4329340

object_name: Childhood Breast Carcinoma


subject: UMLS:C4329340

object_name: breast carcinoma


subject: UMLS:C4329340

object_name: breast cancer


subject: UMLS:C4329340

object_name: renal carcinoma


subject: UMLS:C4329340

object_name: kidney cancer


subject: UMLS:C4329340

object_name: lung cancer


subject: UMLS:C4329340

object_name: lung neoplasm


subject: UMLS:C4329340

object_name: lung carcinoma


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: CHEBI:15927

subject_name: Nicotinamide riboside

object_name: Overweight


subject: CHEBI:15927

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:15927

object_name: Obesity, CTCAE


subject: UNII:PUY08529FK

subject_name: Eleclazine

object_name: Ventricular Arrhythmia by ECG Finding


subject: UNII:PUY08529FK

object_name: Ventricular arrhythmia


subject: UNII:PUY08529FK

object_name: Ventricular Arrhythmia, CTCAE 5.0


subject: UNII:PUY08529FK

object_name: Ventricular Arrhythmia, CTCAE 3.0


subject: UMLS:C5417948

subject_name: HPV Vaccine PRGN-2009

object_name: Metastatic Carcinoma to the Uterine Cervix


subject: UMLS:C5417948

object_name: Cervix carcinoma recurrent


subject: UMLS:C5417948

object_name: Human Papillomavirus-Related Malignant Neoplasm


subject: UMLS:C5417948

object_name: HPV-related carcinoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UMLS:C5556426

subject_name: Keynatinib

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:6503

subject_name: LISINOPRIL

object_name: cardiomyopathy


subject: CHEBI:43755

subject_name: Lisinopril


subject: CHEBI:149504


subject: CHEBI:149504

object_name: Duchenne muscular dystrophy


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: UMLS:C0678449

subject_name: Cannabis substance

object_name: Cannabis use disorder


subject: UMLS:C0678449

object_name: schizophrenia


subject: UMLS:C0678449

object_name: psychosis


subject: UMLS:C0678449

object_name: Psychotic disorder due to a general medical condition


subject: UMLS:C0678449

object_name: Mentally ill chemical abuse


subject: UMLS:C0678449

object_name: Dual diagnosis (psychiatry)


subject: UMLS:C0024808

subject_name: Marihuana


subject: UMLS:C0024808


subject: UMLS:C0024808


subject: UMLS:C0024808


subject: UMLS:C0024808


subject: UMLS:C0024808


subject: UMLS:C4552088

subject_name: Cannabis sativa whole extract


subject: UMLS:C4552088


subject: UMLS:C4552088


subject: UMLS:C4552088


subject: UMLS:C4552088


subject: UMLS:C4552088


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism

object_name: Grasped with hand


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: UMLS:C5237963

subject_name: ADC SKB264

object_name: Childhood Breast Carcinoma


subject: UMLS:C5237963

object_name: breast carcinoma


subject: UMLS:C5237963

object_name: breast cancer


subject: UMLS:C5237963

object_name: malignant epithelial tumor of ovary


subject: UMLS:C5237963

object_name: gastric adenocarcinoma


subject: UMLS:C5237963

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5237963


subject: UMLS:C5237963

object_name: urothelial carcinoma


subject: UMLS:C5237963

object_name: transitional cell carcinoma


subject: CHEBI:95060

subject_name: Dinaciclib

object_name: superficial spreading melanoma


subject: CHEBI:95060

object_name: mucosal melanoma


subject: CHEBI:95060

object_name: Melanoma recurrent


subject: CHEBI:95060

object_name: lentigo maligna melanoma


subject: CHEBI:95060

object_name: nodular malignant melanoma


subject: CHEBI:95060

object_name: acral lentiginous melanoma


subject: CHEBI:52763

object_name: sickle cell disease


subject: GTOPDB:12989

subject_name: toripalimab

object_name: Locally Advanced Hypopharyngeal Carcinoma


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UMLS:C0879636

subject_name: IMC C225


subject: CHEBI:33364

subject_name: Platinum


subject: CHEMBL.COMPOUND:CHEMBL1235478

subject_name: PLATINUM


subject: UMLS:C1171558

subject_name: Platinum metallicum, platinum, Homeopathic preparation


subject: CHEBI:24866

subject_name: salt

object_name: Gitelman syndrome


subject: CHEBI:26710

subject_name: Sodium chloride


subject: UMLS:C3644171

subject_name: tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed

object_name: dengue disease


subject: UMLS:C3644171

object_name: Severe Dengue


subject: UMLS:C3526553

subject_name: diphtheria, tetanus toxoids and acellular pertussis vaccine


subject: UMLS:C3526553


subject: CHEMBL.COMPOUND:CHEMBL2108875

subject_name: TETANUS TOXOID


subject: CHEMBL.COMPOUND:CHEMBL2108875


subject: UMLS:C0039620

subject_name: Tetanus Vaccine


subject: UMLS:C0039620


subject: UMLS:C0982332

subject_name: acellular pertussis vaccine, inactivated


subject: UMLS:C0982332


subject: UMLS:C1614702

subject_name: Naglazyme

object_name: mucopolysaccharidosis type 6


subject: GTOPDB:12966

subject_name: cadonilimab

object_name: Advanced Bile Duct Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: CHEBI:30884

subject_name: glycoloyl group


subject: CHEBI:73890

subject_name: Gly-Cys


subject: PUBCHEM.COMPOUND:154723996

subject_name: Heme arginate

object_name: acute myocardial infarction


subject: PUBCHEM.COMPOUND:154723996

object_name: Acute Myocardial Infarction by ECG Finding


subject: UNII:R1B526117P


subject: UNII:R1B526117P


subject: CHEBI:77655

subject_name: perindopril arginine

object_name: type 2 diabetes mellitus


subject: UNII:XQ43H3V6M1

subject_name: Subasumstat

object_name: lymphoma, non-Hodgkin, familial


subject: UNII:XQ43H3V6M1

object_name: non-Hodgkin lymphoma


subject: MESH:C000730454


subject: MESH:C000730454


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: hypercholesterolemia, familial, 1


subject: CHEBI:60791

subject_name: Xylocard

object_name: pancreatitis


subject: CHEBI:60791

object_name: Pancreatitis, CTCAE 5.0


subject: CHEBI:60791

object_name: Pancreatitis, CTCAE 3.0


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:6456


subject: CHEBI:6456


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Refractory Glioblastoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UMLS:C3641662

object_name: pancreatic neoplasm


subject: UMLS:C3641662

object_name: exocrine pancreatic carcinoma


subject: UMLS:C3641662

object_name: malignant pancreatic neoplasm


subject: CHEBI:94534

subject_name: olanzapine

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:94534

object_name: Complications of bone marrow transplant


subject: UMLS:C5434105

subject_name: Injection, sacituzumab govitecan-hziy, 2.5 mg

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C5434105

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C5434105

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C3826787

subject_name: Adenosylmethionine

object_name: HIV infection


subject: UNII:MZ37792Y8J

subject_name: Oprozomib

object_name: Waldenstrom macroglobulinemia


subject: UMLS:C2984209


subject: CHEBI:5775

subject_name: Hydralazine

object_name: cardio-renal syndrome


subject: CHEBI:3757

subject_name: Clonidine

object_name: pain agnosia


subject: CHEBI:3757

object_name: Pain insensitivity


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Visual Acuity


subject: CHEBI:3441

subject_name: Carvedilol

object_name: acute coronary syndrome


subject: CHEBI:2914

subject_name: Atracurium

object_name: no feeling or sensation of skin


subject: CHEBI:2914

object_name: Sensory Loss


subject: UMLS:C1739076

object_name: Metastatic Cutaneous Melanoma


subject: UMLS:C1739076

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C1739076

object_name: metastatic melanoma


subject: UMLS:C1739076

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS

object_name: multiple sclerosis


subject: GTOPDB:11345

subject_name: avdoralimab

object_name: Pemphigoid


subject: CHEMBL.COMPOUND:CHEMBL4594463

subject_name: AVDORALIMAB


subject: UMLS:C5207042


subject: UMLS:C4733632

subject_name: Clostridium butyricum CBM 588 Probiotic Strain

object_name: Clostridium difficile colitis


subject: UMLS:C4733632

object_name: clostridium difficile infection


subject: UNII:6897GXD6OE

object_name: Arrhythmia


subject: UMLS:C0935802

object_name: liver neoplasm


subject: CHEBI:5103

subject_name: Flumazenil

object_name: insomnia


subject: CHEBI:5103

object_name: Insomnia, CTCAE 3.0


subject: CHEBI:5103

object_name: Insomnia, CTCAE 5.0


subject: UMLS:C3640989

object_name: pemphigus


subject: PUBCHEM.COMPOUND:89455219

subject_name: tirabrutinib


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Agitation on recovery from sedation


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH

object_name: Respiratory complication


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:231614

subject_name: Nivolumab

object_name: oropharyngeal carcinoma


subject: CHEBI:231614

object_name: oropharynx cancer


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: malignant neoplasm of breast staging


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:76842

object_name: respiratory tract infectious disorder


subject: CHEBI:76842

object_name: Bacterial resistance


subject: CHEBI:76842

object_name: respiratory failure


subject: CHEBI:76842

object_name: Respiratory Failure, CTCAE


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin


subject: PUBCHEM.COMPOUND:3467


subject: PUBCHEM.COMPOUND:3467


subject: UNII:3LWJ2H14I9

subject_name: VONAPANITASE

object_name: chronic kidney disease


subject: UNII:3LWJ2H14I9

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C4310574

subject_name: Vonapanitase


subject: UMLS:C4310574


subject: DRUGBANK:DB05141

object_name: liver carcinoma


subject: UMLS:C0368651

subject_name: Alpha-thymosin

object_name: acute respiratory distress syndrome


subject: UMLS:C0368651

object_name: adult acute respiratory distress syndrome


subject: CHEBI:28364

subject_name: Icosapent

object_name: decubitus ulcer


subject: CHEBI:36005

subject_name: docosahexaenoic acid


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:31980

subject_name: Perflutren

object_name: Metastatic malignant neoplasm to liver


subject: CHEBI:31980

object_name: colon carcinoma


subject: CHEBI:31980

object_name: colorectal cancer


subject: CHEBI:31980

object_name: colon cancer


subject: UMLS:C3641866

object_name: Hormone-dependent prostate cancer


subject: UNII:CI43QFE22O

object_name: glioma


subject: UNII:CI43QFE22O

object_name: malignant glioma


subject: UNII:CI43QFE22O

object_name: Brain Stem Glioblastoma


subject: UNII:CI43QFE22O

object_name: glioma susceptibility 1


subject: PUBCHEM.COMPOUND:340558

subject_name: Cytochlor

object_name: Neck Carcinoma


subject: PUBCHEM.COMPOUND:340558

object_name: head and neck neoplasm


subject: PUBCHEM.COMPOUND:340558

object_name: head and neck cancer


subject: UNII:0NIZ8H6OL8

subject_name: Tetrahydrouridine


subject: UNII:0NIZ8H6OL8


subject: CHEBI:85252

subject_name: synaptamide

object_name: EXCESS LMW-DNA


subject: CHEBI:89608

subject_name: Cervonoyl ethanolamide


subject: UNII:F0GIZ22IJH

subject_name: Reproxalap

object_name: alopecia areata


subject: UMLS:C5449399


subject: GTOPDB:9107

subject_name: cabiralizumab

object_name: triple-negative breast carcinoma


subject: GTOPDB:9107

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:5FJL6W0640

subject_name: CABIRALIZUMAB


subject: UNII:5FJL6W0640


subject: UMLS:C4085968


subject: UMLS:C4085968


subject: PUBCHEM.COMPOUND:147912

subject_name: Posaconazole

object_name: COVID-19 respiratory infection


subject: CHEBI:47657

subject_name: Roflumilast

object_name: Presenile dementia


subject: CHEBI:47657

object_name: dementia


subject: CHEBI:32999

subject_name: europium atom


subject: CHEBI:32999


subject: CHEBI:233437


subject: CHEBI:233437


subject: CHEBI:176844

subject_name: Niraparib

object_name: tumor of uterus


subject: UNII:2QD3F58224

object_name: chronic hepatitis C virus infection


subject: UNII:GOY102QI5I

object_name: type 2 diabetes mellitus


subject: UMLS:C0002287

subject_name: alpha-Lactalbumin


subject: UMLS:C5703447

subject_name: Recombinant Alpha-Lactalbumin


subject: UMLS:C2826152

subject_name: fluorescein sodium injection

object_name: stage IA melanoma


subject: UMLS:C2826152

object_name: Melanoma recurrent


subject: UMLS:C0304229

subject_name: Experimental drug

object_name: Childhood Breast Carcinoma


subject: UMLS:C0304229

object_name: breast carcinoma


subject: UMLS:C0304229

object_name: breast cancer


subject: CHEBI:7773

subject_name: Ondansetron


subject: CHEBI:7773


subject: CHEBI:7773


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol

object_name: Weight loss


subject: PUBCHEM.COMPOUND:3080587

object_name: Weight Loss, CTCAE


subject: CHEBI:60802

subject_name: ropivacaine

object_name: adult disease


subject: CHEBI:9316

subject_name: Sufentanil

object_name: liver disorder


subject: CHEBI:9316


subject: CHEBI:16118

subject_name: Berberine

object_name: Schizophrenia Spectrum and Other Psychotic Disorders


subject: CHEBI:6801

subject_name: Metformin

object_name: autism, susceptibility to, X-linked 2


subject: UMLS:C3245295

subject_name: Tenivac

object_name: tetanus


subject: UMLS:C3245295

object_name: diphtheria


subject: UMLS:C3245295

object_name: Exposure to pollution


subject: UMLS:C3245295

object_name: Innate Inflammatory Response


subject: UMLS:C3245295

object_name: Environmental Exposure


subject: UMLS:C3245295

object_name: environmental exposure (history)


subject: UMLS:C4524460

subject_name: Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10

object_name: Refractory acute myeloid leukemia


subject: UMLS:C4524460

object_name: Recurrent Acute Myeloid Leukemia


subject: UMLS:C4524460

object_name: myelodysplastic syndrome with excess blasts


subject: UMLS:C4524460

object_name: Refractory Acute Lymphoblastic Leukemia


subject: UMLS:C4524460

object_name: Acute myeloid leukemia in remission


subject: UMLS:C4524460

object_name: Acute lymphoblastic leukemia recurrent


subject: UMLS:C4524460

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: UMLS:C4524460

object_name: Recurrent Mixed Phenotype Acute Leukemia


subject: UMLS:C4524460

object_name: Refractory Mixed Phenotype Acute Leukemia


subject: UMLS:C4524460

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C4524460

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UMLS:C4524460

object_name: Acute lymphoid leukemia in remission


subject: UMLS:C4524460

object_name: juvenile myelomonocytic leukemia


subject: UMLS:C4524460

object_name: chronic myelomonocytic leukemia


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: UMLS:C0376562

subject_name: Recombinant Granulocyte Colony Stimulating Factor


subject: UMLS:C0376562


subject: UMLS:C0376562


subject: UMLS:C0376562


subject: UMLS:C0376562


subject: UMLS:C0376562


subject: UMLS:C0376562


subject: UMLS:C0376562


subject: UMLS:C0376562


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: GTOPDB:10067

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: GTOPDB:10067

object_name: primary cutaneous T-cell lymphoma


subject: UMLS:C2986404


subject: UMLS:C2986404


subject: CHEBI:91432

subject_name: Brivanib

object_name: ovarian cancer


subject: CHEBI:91432

object_name: ovarian neoplasm


subject: CHEBI:91432

object_name: ovarian carcinoma


subject: CHEBI:4806

subject_name: Epigallocatechin gallate

object_name: cancer


subject: CHEBI:4806

object_name: nervous system cancer


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib

object_name: neuroendocrine carcinoma


subject: UMLS:C1709429


subject: CHEBI:39585

subject_name: Carbidopa

object_name: Urinary incontinence


subject: CHEBI:39585

object_name: Urinary Incontinence, CTCAE 5.0


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol


subject: PUBCHEM.COMPOUND:521372


subject: UMLS:C5446566

subject_name: B-cell Lymphoma-2 Inhibitor BGB-11417

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5446566

object_name: acute myeloid leukemia


subject: UMLS:C5446566

object_name: Myelodysplasia


subject: UMLS:C5446566


subject: PUBCHEM.COMPOUND:147912

subject_name: Posaconazole


subject: CHEBI:75275

subject_name: Tetradecyl hydrogen sulfate (ester)

object_name: Pedal edema


subject: CHEMBL.COMPOUND:CHEMBL2108494

subject_name: INTERFERON

object_name: hepatitis C


subject: UMLS:C3652465

subject_name: Interferon


subject: UMLS:C1610033

subject_name: Interferon Alpha, Human

object_name: HIV infection


subject: UMLS:C0751598

subject_name: Alferon


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: restrictive pulmonary disease


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:74705

subject_name: Met-Leu

object_name: osteoarthritis, hip


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UMLS:C1541591

subject_name: omburtamab I-131

object_name: malignant soft tissue neoplasm


subject: UMLS:C1541591

object_name: sarcoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Recurrent Thyroid Gland Medullary Carcinoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: hormone-resistant prostate carcinoma


subject: CHEBI:8499

subject_name: Propranolol

object_name: Stomach cancer


subject: CHEBI:8499

object_name: gastric cancer


subject: CHEBI:59495

subject_name: CIDOFOVIR

object_name: transplantation infection


subject: CHEBI:530615


subject: CHEBI:134514


subject: CHEBI:3696

subject_name: Cidofovir


subject: UNII:XSZ53G39H5

subject_name: Brolucizumab

object_name: Pachychoroid neovasculopathy


subject: UNII:BK76465IHM

subject_name: Zantac


subject: CHEBI:8776

subject_name: ranitidine


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: lymphoblastic lymphoma


subject: UMLS:C1271482

subject_name: MabCampath

object_name: acute lymphoblastic leukemia


subject: UMLS:C1271482


subject: UMLS:C1271482

object_name: T-cell adult acute lymphocytic leukemia


subject: CHEBI:567361

subject_name: Cladribine


subject: CHEBI:567361


subject: CHEBI:7465

subject_name: Naltrexone

object_name: dermatitis


subject: CHEBI:7465

object_name: Dermatitis


subject: CHEBI:7465

object_name: atopic eczema


subject: CHEBI:7465

object_name: Pruritus, CTCAE


subject: CHEBI:7465

object_name: Pruritus


subject: CHEBI:231683

subject_name: Anakinra

object_name: Insulin resistance


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: UNII:W39886N0ZG

object_name: head and neck squamous cell carcinoma


subject: UNII:W39886N0ZG


subject: UNII:W39886N0ZG

object_name: non-small cell lung carcinoma


subject: UNII:W39886N0ZG

object_name: bladder tumor


subject: UNII:W39886N0ZG

object_name: gastric adenocarcinoma


subject: UNII:W39886N0ZG

object_name: renal cell carcinoma


subject: UNII:W39886N0ZG

object_name: colorectal neoplasm


subject: UNII:W39886N0ZG

object_name: breast neoplasm


subject: UMLS:C4329215


subject: UMLS:C4329215


subject: UMLS:C4329215


subject: UMLS:C4329215


subject: UMLS:C4329215


subject: UMLS:C4329215


subject: UMLS:C4329215


subject: UMLS:C4329215


subject: CHEBI:6427

subject_name: Leuprolide

object_name: Neoplasm of salivary gland duct


subject: UNII:70FJN2AW22


subject: DRUGBANK:DB19133

subject_name: Rezvilutamide


subject: UMLS:C5222453

subject_name: Insulin Human Injection

object_name: type 2 diabetes mellitus


subject: UMLS:C0733741

subject_name: Microgynon

object_name: Drug Interactions


subject: UMLS:C2717562


subject: CHEBI:59043

subject_name: PAL

object_name: influenza


subject: CHEBI:18258

subject_name: Liothyronine

object_name: thyroid gland papillary carcinoma


subject: UMLS:C2936843

subject_name: l-Triiodothyronine [EPC]

object_name: hypothyroidism


subject: UMLS:C2936843

object_name: Hypothyroidism, CTCAE


subject: UMLS:C2936843


subject: CHEBI:27300

subject_name: Ergocalciferol

object_name: Cognition disorders in children


subject: CHEBI:27300

object_name: digestive system infectious disorder


subject: CHEBI:27300

object_name: Diagnosis, Psychiatric


subject: CHEBI:27300

object_name: dermatitis


subject: CHEBI:27300

object_name: Eczema, CTCAE


subject: CHEBI:27300

object_name: croup


subject: CHEBI:27300

object_name: Subglottic laryngitis


subject: UMLS:C3644171

subject_name: tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed

object_name: Whooping cough


subject: UMLS:C3526553

subject_name: diphtheria, tetanus toxoids and acellular pertussis vaccine


subject: CHEBI:74705

subject_name: Met-Leu

object_name: strabismus


subject: CHEBI:74705

object_name: strabismus on exam (physical finding)


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex


subject: PUBCHEM.COMPOUND:74030550


subject: PUBCHEM.COMPOUND:74030550

object_name: childhood acute lymphoblastic leukemia


subject: CHEBI:40279

subject_name: Allopurinol

object_name: Acute kidney injury caused by contrast agent


subject: CHEBI:40279

object_name: contrast-induced nephropathy


subject: CHEBI:31596

subject_name: Febuxostat


subject: UMLS:C5206943

subject_name: Radspherin

object_name: Carcinoma of peritoneum


subject: UMLS:C5206943

object_name: peritoneal carcinoma


subject: UMLS:C5206943

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Recurrent Hepatocellular Carcinoma


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: UNII:S098K6HGD9

object_name: Unresectable Hepatocellular Carcinoma


subject: UNII:S098K6HGD9


subject: UMLS:C4684904

subject_name: Aldoxorubicin Hydrochloride


subject: UMLS:C4684904


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:31348


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UNII:PQX0D8J21J


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C4722367


subject: UMLS:C4722367


subject: DRUGBANK:DB17529


subject: DRUGBANK:DB17529


subject: DRUGBANK:DB17530


subject: DRUGBANK:DB17530


subject: UMLS:C4758796


subject: UMLS:C4758796


subject: UNII:FIJ3OLQ3N8


subject: UNII:FIJ3OLQ3N8


subject: UMLS:C2826130

subject_name: Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207


subject: UMLS:C2826130


subject: UMLS:C4722124


subject: UMLS:C4722124


subject: UNII:B0L24T8TB7


subject: UNII:B0L24T8TB7


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: UMLS:C3658787


subject: UMLS:C3658787


subject: UNII:KXG2PJ551I

subject_name: Avelumab


subject: UNII:KXG2PJ551I


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UNII:6R5034F862

object_name: Chronic obstructive pulmonary disease of horses


subject: UNII:6R5034F862

object_name: COPD, severe early onset


subject: UNII:6R5034F862

object_name: chronic obstructive pulmonary disease


subject: CHEBI:6129

subject_name: Ketorolac

object_name: cesarean section; complications


subject: CHEBI:6129

object_name: Afterbirth pain


subject: PUBCHEM.COMPOUND:134506

subject_name: Dehydroandrosterone

object_name: Postmenopausal symptoms


subject: PUBCHEM.COMPOUND:134506

object_name: Menopause present (finding)


subject: PUBCHEM.COMPOUND:134506

object_name: Menopause


subject: PUBCHEM.COMPOUND:134506

object_name: Recurrent urinary tract infections


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:9449

subject_name: Terbutaline

object_name: Fetal distress


subject: UNII:0P49L952WZ

subject_name: Andrographis paniculata extract


subject: UMLS:C1675704

object_name: multiple sclerosis


subject: CHEBI:37845

subject_name: growth hormone

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:37845

object_name: metabolic syndrome X


subject: PUBCHEM.COMPOUND:170907453

subject_name: Growth hormone


subject: PUBCHEM.COMPOUND:170907453


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: UMLS:C0037663


subject: PR:000007968

subject_name: somatotropin


subject: PR:000007968


subject: UniProtKB:P47737

subject_name: X19F_ECOLI X polypeptide (sprot)

object_name: Disseminated Malignant Neoplasm


subject: UniProtKB:P47737

object_name: Embolism, Tumor


subject: UniProtKB:P47737

object_name: Neoplasm Metastasis


subject: UniProtKB:P47737

object_name: head and neck squamous cell carcinoma


subject: UniProtKB:P47737

object_name: melanoma


subject: UniProtKB:P47737

object_name: non-small cell lung carcinoma


subject: UniProtKB:P47737

object_name: urothelial carcinoma


subject: UniProtKB:P47737

object_name: transitional cell carcinoma


subject: UniProtKB:P47737

object_name: colorectal cancer


subject: UniProtKB:P47737

object_name: colorectal carcinoma


subject: UniProtKB:P47737

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UniProtKB:P47737

object_name: ovarian cancer


subject: UniProtKB:P47737

object_name: ovarian neoplasm


subject: UniProtKB:P47737

object_name: ovarian carcinoma


subject: UniProtKB:P47737

object_name: Childhood Breast Carcinoma


subject: UniProtKB:P47737

object_name: breast carcinoma


subject: UniProtKB:P47737

object_name: breast cancer


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: pancreatic neoplasm


subject: CHEBI:168243

object_name: exocrine pancreatic carcinoma


subject: CHEBI:168243

object_name: malignant pancreatic neoplasm


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: CHEBI:39867


subject: UMLS:C5556639

subject_name: Lutetium Lu 177-FAP-2286

object_name: Childhood Solid Neoplasm


subject: UMLS:C5556639

object_name: Adult Solid Neoplasm


subject: UMLS:C5556639

object_name: Solid Neoplasm


subject: UMLS:C5447255

subject_name: Gallium Ga 68 FAP-2286


subject: UMLS:C5447255


subject: UMLS:C5447255


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Stage I Pleural Malignant Mesothelioma AJCC v7


subject: UNII:52CMI0WC3Y

object_name: Stage II Pleural Malignant Mesothelioma AJCC v7


subject: UNII:52CMI0WC3Y

object_name: Stage IB Pleural Malignant Mesothelioma AJCC v7


subject: UNII:52CMI0WC3Y

object_name: Stage IA Pleural Malignant Mesothelioma AJCC v7


subject: UNII:52CMI0WC3Y

object_name: malignant biphasic mesothelioma


subject: UNII:52CMI0WC3Y

object_name: malignant epithelioid mesothelioma


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Stage III Pleural Malignant Mesothelioma AJCC v7


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: UMLS:C5238055

subject_name: Tengonermin

object_name: diffuse large B-cell lymphoma


subject: UMLS:C1143119

subject_name: Zafiride


subject: CHEBI:5280

subject_name: Gatifloxacin

object_name: Antibiotic Resistance, Microbial


subject: UMLS:C5238367

subject_name: RET/SRC Inhibitor TPX-0046

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C5238367

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5238367

object_name: RET gene mutation


subject: UMLS:C5238367

object_name: medullary thyroid gland carcinoma


subject: UMLS:C5238367

object_name: non-small cell lung carcinoma


subject: CHEBI:49662

subject_name: Indomethacin

object_name: congenital heart disease


subject: CHEBI:49662

object_name: cardiovascular disorder


subject: CHEBI:49662

object_name: heart disorder


subject: CHEBI:149504

object_name: radiation pneumonitis


subject: CHEBI:149504

object_name: Pulmonary Complication


subject: CHEBI:149504

object_name: Dyspnea


subject: CHEBI:149504

object_name: Dyspnea, CTCAE


subject: CHEBI:149504

object_name: cardiovascular surgery result: dyspnea


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6541


subject: UMLS:C0742246

subject_name: CHEMOTHERAPY CIS PLATIN

object_name: HPV positive oropharyngeal squamous cell carcinoma


subject: DRUGBANK:DB17293

subject_name: Hiltonol

object_name: cancer


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: UNII:6Y5629322X

subject_name: Alvelestat


subject: CHEBI:184910

subject_name: Rotigotine

object_name: restless legs syndrome, susceptibility to, 1


subject: UNII:366037O6O7

subject_name: Irosustat

object_name: Carcinoma breast stage IV


subject: UNII:366037O6O7

object_name: Locally advanced breast cancer


subject: MESH:C000723557


subject: UMLS:C5447426

subject_name: HSV- thymidine Kinase-m2/hGM-CSF Genes-encoding GEN2


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: nicotine dependence


subject: UNII:7JNY4KV3NK

subject_name: OCIPERLIMAB

object_name: Metastatic non-small cell lung cancer


subject: UNII:7JNY4KV3NK

object_name: Non-small cell lung cancer stage IIIB


subject: UMLS:C5417829

subject_name: Ociperlimab


subject: UMLS:C5417829


subject: CHEBI:16919

subject_name: Creatine

object_name: Effects of chemotherapy


subject: CHEBI:16919

object_name: Muscle Atrophy


subject: UNII:T7K20Y2GWY

subject_name: Corifollitropin alfa

object_name: Androgen excess


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: Abdominal pain


subject: PUBCHEM.COMPOUND:46783403

object_name: Abdominal Pain, CTCAE


subject: PUBCHEM.COMPOUND:46783403

object_name: cystic fibrosis


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Arteriovenous fistula occlusion


subject: CHEBI:7959

subject_name: Penicillamine


subject: UMLS:C2095490

subject_name: corticosteroid injection

object_name: chronic pain (diagnosis)


subject: UMLS:C2095490

object_name: Chronic pain


subject: CHEBI:229764

subject_name: Selinexor

object_name: liver carcinoma


subject: PR:000011050

subject_name: kinetochore protein NDC80

object_name: Cardiovascular event


subject: PR:000011050

object_name: Vomiting, CTCAE


subject: PR:000011050

object_name: Vomiting


subject: UniProtKB:P0AED9

subject_name: DCM_ECOLI DNA-cytosine methyltransferase (sprot)


subject: UniProtKB:P0AED9


subject: UniProtKB:P0AED9


subject: PR:000001803

subject_name: C-C motif chemokine 28


subject: PR:000001803


subject: PR:000001803


subject: PR:000022407

subject_name: DNA-cytosine methyltransferase


subject: PR:000022407


subject: PR:000022407


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Arterial thrombosis


subject: UNII:XC0UT08SNJ

object_name: neuroendocrine carcinoma


subject: UNII:54T74394F8

subject_name: IADADEMSTAT


subject: MESH:C000730035

subject_name: iadademstat


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UMLS:C0002525

subject_name: Amino Acids, Essential

object_name: BODY COMPOSITION, BENEFICIAL


subject: UMLS:C0002525

object_name: type 2 diabetes mellitus


subject: UMLS:C0002525

object_name: Insulin resistance


subject: UMLS:C0002525

object_name: Fatty Liver


subject: CHEBI:32696


subject: CHEBI:32696


subject: CHEBI:32696


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:16467


subject: PUBCHEM.COMPOUND:157010068

subject_name: Calcium citrate

object_name: cardiovascular disorder


subject: UNII:MLM29U2X85


subject: UNII:J89QT81NBQ

object_name: velocardiofacial syndrome


subject: UNII:J89QT81NBQ

object_name: 22q11 Deletion Syndrome


subject: UMLS:C4490519


subject: UMLS:C4490519


subject: UMLS:C1881373

subject_name: Synthetic Levothyroxine

object_name: Wound healed (finding)


subject: UMLS:C1881373

object_name: Neck Carcinoma


subject: UMLS:C1881373

object_name: head and neck neoplasm


subject: UMLS:C1881373

object_name: head and neck cancer


subject: UMLS:C1881373

object_name: hypothyroidism; surgery


subject: UMLS:C1881373

object_name: laryngeal carcinoma


subject: UMLS:C1881373

object_name: larynx cancer


subject: UMLS:C1881373

object_name: Laryngeal Fistula


subject: UMLS:C1881373

object_name: Laryngeal Fistula, CTCAE


subject: CHEBI:18332

subject_name: Levothyroxine


subject: CHEBI:18332


subject: CHEBI:18332


subject: CHEBI:18332


subject: CHEBI:18332


subject: CHEBI:18332


subject: CHEBI:18332


subject: CHEBI:18332


subject: CHEBI:18332


subject: UMLS:C4077912

object_name: chronic kidney disease


subject: UMLS:C4077912

object_name: Chronic uremia


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: pathological complete response


subject: CHEBI:45863

object_name: Extrapulmonary Small Cell Carcinoma


subject: CHEBI:45863


subject: GTOPDB:9592

subject_name: tislelizumab


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: CHEBI:10127

subject_name: Zonisamide

object_name: obstructive sleep apnea syndrome


subject: CHEBI:10127

object_name: sleep apnea


subject: CHEBI:10127

object_name: Sleep Apnea, CTCAE


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Neck Neoplasms


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: DRUGBANK:DB17293

subject_name: Hiltonol

object_name: cervical cancer


subject: DRUGBANK:DB17293

object_name: cervical carcinoma


subject: DRUGBANK:DB17293

object_name: transitional cell carcinoma


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293

object_name: microsatellite instability high


subject: DRUGBANK:DB17293

object_name: squamous cell carcinoma


subject: DRUGBANK:DB17293

object_name: carcinoma of esophagus


subject: DRUGBANK:DB17293

object_name: esophageal cancer


subject: DRUGBANK:DB17293

object_name: Childhood Esophageal Carcinoma


subject: DRUGBANK:DB17293

object_name: neoplasm of esophagus


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: PUBCHEM.COMPOUND:108018

subject_name: N-chlorotaurine

object_name: Irritable bowel syndrome with diarrhea


subject: CHEBI:68551

subject_name: Linaclotide

object_name: colorectal adenoma


subject: CHEBI:68551

object_name: Stage 0 Colorectal Cancer AJCC v8


subject: CHEBI:68551

object_name: Stage IIC Colorectal Cancer AJCC v8


subject: CHEBI:68551

object_name: Stage IIIC Colorectal Cancer AJCC v8


subject: CHEBI:68551

object_name: Stage I Colorectal Cancer AJCC v8


subject: CHEBI:68551

object_name: Stage II Colorectal Cancer AJCC v8


subject: CHEBI:68551

object_name: Stage III Colorectal Cancer AJCC v8


subject: CHEBI:68551

object_name: Stage IIA Colorectal Cancer AJCC v8


subject: CHEBI:68551

object_name: Stage IIB Colorectal Cancer AJCC v8


subject: CHEBI:68551

object_name: Stage IIIA Colorectal Cancer AJCC v8


subject: CHEBI:68551

object_name: Stage IIIB Colorectal Cancer AJCC v8


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: stroke disorder


subject: UNII:LKC0U3A8NJ

object_name: cerebrovascular disorder


subject: UNII:LKC0U3A8NJ

object_name: Stroke (heart beat)


subject: UNII:LKC0U3A8NJ

object_name: Stroke, CTCAE


subject: UNII:LKC0U3A8NJ

object_name: myocardial infarction


subject: UNII:LKC0U3A8NJ

object_name: Myocardial Infarction, CTCAE


subject: UNII:LKC0U3A8NJ

object_name: Myocardial Infarction by ECG Finding


subject: UMLS:C0524639

subject_name: urofollitropin

object_name: male infertility


subject: UMLS:C0524639

object_name: inability to impregnate


subject: UMLS:C2987725

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: Raynaud disease


subject: UMLS:C0006055

subject_name: Botulinum Toxins


subject: UMLS:C1883356

subject_name: Tocosol

object_name: Childhood Breast Carcinoma


subject: UMLS:C1883356

object_name: breast carcinoma


subject: UMLS:C1883356

object_name: breast cancer


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Post-polycythemia vera myelofibrosis


subject: CHEBI:231614


subject: CHEBI:231614

object_name: Hepatomegaly


subject: CHEBI:231614

object_name: Splenomegaly


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: Eye Burns


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: GTOPDB:13796

subject_name: serplulimab

object_name: colon carcinoma


subject: GTOPDB:13796

object_name: colon cancer


subject: CHEMBL.COMPOUND:CHEMBL4594550

subject_name: SERPLULIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594550


subject: UMLS:C4745029

subject_name: HLX 10


subject: UMLS:C4745029


subject: PUBCHEM.COMPOUND:6331784

subject_name: Sodium risedronate

object_name: bone Paget disease


subject: CHEBI:8869

subject_name: Risedronic acid


subject: CHEBI:50692

subject_name: Mifepristone

object_name: Medication interaction potentiation


subject: CHEBI:94366

subject_name: itraconazole


subject: MESH:D013024

subject_name: Soybean Oil

object_name: total parenteral nutrition-induced cholestasis


subject: CHEBI:166975

subject_name: soybean oil


subject: DRUGBANK:DB09422

subject_name: Soybean oil


subject: UMLS:C0361142

subject_name: Measles/rubella vaccine

object_name: rubella


subject: UMLS:C0361142

object_name: yellow fever


subject: UMLS:C0361142

object_name: measles


subject: UMLS:C0072053

subject_name: procollagen Type I N-terminal peptide


subject: UMLS:C0072053


subject: UMLS:C0072053


subject: UNII:30868AY0IF

object_name: no feeling or sensation of skin


subject: UNII:30868AY0IF

object_name: Sensory Loss


subject: CHEBI:135193

subject_name: Fospropofol


subject: CHEBI:135193


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: MESH:C000723557

object_name: primary peritoneal carcinoma


subject: MESH:C000723557

object_name: papillary serous cystadenocarcinoma


subject: MESH:C000723557

object_name: peritoneal carcinoma


subject: MESH:C000723557

object_name: fallopian tube carcinoma


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Chlamydia trachomatis infection in pregnancy


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: UMLS:C5783561

subject_name: Tri-specific NK Cell Engager Therapeutic Agent CC-92328


subject: CHEBI:49134

object_name: endometriosis


subject: UMLS:C0597354

subject_name: Radiotracers


subject: CHEBI:6801

subject_name: Metformin

object_name: Ischemic reperfusion injury


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN

object_name: Primary malignant neoplasm


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: Anus absent


subject: PUBCHEM.COMPOUND:6096882

object_name: hereditary anorectal anomalies


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: PUBCHEM.COMPOUND:132451761

subject_name: Forteo

object_name: periodontitis


subject: PUBCHEM.COMPOUND:132451761

object_name: Osteopenia


subject: UMLS:C0376564


subject: UMLS:C0376564


subject: PUBCHEM.COMPOUND:26945

subject_name: Aqua-cem

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:26945

object_name: Adult Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:26945

object_name: childhood myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:26945

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:94463

object_name: hepatitis E


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:28741

subject_name: Sodium fluoride

object_name: prostate cancer


subject: CHEBI:28741

object_name: prostate neoplasm


subject: PUBCHEM.COMPOUND:138376495

subject_name: Cefiderocol

object_name: urinary tract infection


subject: PUBCHEM.COMPOUND:138376495

object_name: Recurrent urinary tract infections


subject: CHEBI:50733

subject_name: nutraceutical

object_name: bone giant cell tumor


subject: CHEBI:45783

subject_name: Imatinib

object_name: stage II Merkel cell carcinoma


subject: CHEBI:45783

object_name: stage III Merkel cell carcinoma


subject: CHEBI:45783

object_name: Recurrent Merkel Cell Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1742985

subject_name: ANRUKINZUMAB

object_name: ulcerative colitis


subject: UMLS:C2987420

subject_name: anrukinzumab


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: Burn, CTCAE


subject: CHEBI:30776

subject_name: hexanoic acid

object_name: Subcutaneous fat disorder


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Malignant ascites


subject: CHEBI:6121

subject_name: Ketamine

object_name: Widespread Chronic Pain


subject: CHEBI:53667

subject_name: Cefadroxil

object_name: Prosthetic joint infection


subject: CHEBI:53667

object_name: MSSA colonization


subject: CHEBI:53667

object_name: chronic kidney disease


subject: CHEBI:53667

object_name: Overweight or obesity


subject: CHEBI:53667

object_name: inflammatory disease


subject: CHEBI:53667

object_name: Autoimmunity


subject: CHEBI:53667

object_name: Tobacco user


subject: CHEBI:53667

object_name: Tobacco use history


subject: CHEBI:53667

object_name: Encounter due to tobacco use


subject: CHEBI:53667

object_name: type 2 diabetes mellitus


subject: CHEBI:53667

object_name: Diabetes


subject: CHEBI:53667

object_name: diabetes mellitus


subject: CHEBI:53667

object_name: methicillin-resistant staphylococcus aureus infectious disease


subject: PUBCHEM.COMPOUND:520990


subject: PUBCHEM.COMPOUND:520990


subject: PUBCHEM.COMPOUND:520990


subject: PUBCHEM.COMPOUND:520990


subject: PUBCHEM.COMPOUND:520990


subject: PUBCHEM.COMPOUND:520990


subject: PUBCHEM.COMPOUND:520990


subject: PUBCHEM.COMPOUND:520990


subject: PUBCHEM.COMPOUND:520990


subject: PUBCHEM.COMPOUND:520990


subject: PUBCHEM.COMPOUND:520990


subject: PUBCHEM.COMPOUND:520990


subject: PUBCHEM.COMPOUND:520990


subject: CHEBI:3479


subject: CHEBI:3479


subject: CHEBI:3479


subject: CHEBI:3479


subject: CHEBI:3479


subject: CHEBI:3479


subject: CHEBI:3479


subject: CHEBI:3479


subject: CHEBI:3479


subject: CHEBI:3479


subject: CHEBI:3479


subject: CHEBI:3479


subject: CHEBI:3479


subject: CHEBI:3535

subject_name: Cephalexin


subject: CHEBI:3535


subject: CHEBI:3535


subject: CHEBI:3535


subject: CHEBI:3535


subject: CHEBI:3535


subject: CHEBI:3535


subject: CHEBI:3535


subject: CHEBI:3535


subject: CHEBI:3535


subject: CHEBI:3535


subject: CHEBI:3535


subject: CHEBI:3535


subject: CHEBI:3534


subject: CHEBI:3534


subject: CHEBI:3534


subject: CHEBI:3534


subject: CHEBI:3534


subject: CHEBI:3534


subject: CHEBI:3534


subject: CHEBI:3534


subject: CHEBI:3534


subject: CHEBI:3534


subject: CHEBI:3534


subject: CHEBI:3534


subject: CHEBI:3534


subject: CHEBI:60648

subject_name: DOXYCYCLINE


subject: CHEBI:60648


subject: CHEBI:60648


subject: CHEBI:60648


subject: CHEBI:60648


subject: CHEBI:60648


subject: CHEBI:60648


subject: CHEBI:60648


subject: CHEBI:60648


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: CHEBI:60799

subject_name: Esketamine

object_name: traumatic encephalopathy


subject: CHEBI:60799

object_name: traumatic brain injury


subject: CHEBI:60799

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: CHEBI:60799

object_name: intracerebral hemorrhage


subject: CHEBI:29385

subject_name: Octasulfur

object_name: scabies


subject: CHEBI:15138


subject: UMLS:C0304490

subject_name: Potassium Sparing Diuretics

object_name: Heart failure with reduced ejection fraction


subject: UMLS:C0304490

object_name: heart failure


subject: UMLS:C0304490

object_name: Heart Failure, CTCAE


subject: UMLS:C0304490

object_name: Heart failure NYHA class III


subject: UMLS:C0304490

object_name: Heart failure NYHA class II


subject: UMLS:C0304490

object_name: Heart failure NYHA class IV


subject: PUBCHEM.COMPOUND:165360157

subject_name: Nangibotide


subject: UNII:59HD7BLX9H

subject_name: NANGIBOTIDE


subject: UMLS:C5203177

subject_name: Ramucirumab Liquid Injection

object_name: non-small cell lung carcinoma


subject: UMLS:C5203177

object_name: colorectal carcinoma


subject: UMLS:C5203177

object_name: Stomach cancer


subject: UMLS:C5203177

object_name: gastric cancer


subject: UMLS:C1134477

subject_name: iodine I 131 monoclonal antibody CC49-deltaCH2

object_name: Recurrent Rectal Cancer


subject: UMLS:C1134477

object_name: Colon cancer recurrent


subject: UMLS:C1134477

object_name: Stage IV Rectal Cancer AJCC v8


subject: UMLS:C1134477

object_name: Stage IV Rectal Cancer AJCC v7


subject: UMLS:C1134477

object_name: Rectal cancer stage IV


subject: UMLS:C1134477

object_name: Stage IV Rectal Cancer AJCC v6


subject: UMLS:C1134477

object_name: Stage IV Colon Cancer AJCC v8


subject: UMLS:C1134477

object_name: Stage IV Colon Cancer AJCC v6


subject: UMLS:C1134477

object_name: Stage IV Colon Cancer AJCC v7


subject: UMLS:C1134477

object_name: Malignant neoplasm of colon stage IV


subject: UMLS:C1134477

object_name: rectum adenocarcinoma


subject: UMLS:C1134477

object_name: colon adenocarcinoma


subject: UMLS:C5706525

subject_name: PSMA-targeting T-cell Redirecting Agent JNJ-80038114

object_name: prostate cancer


subject: UMLS:C5706525

object_name: prostate neoplasm


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: prostate carcinoma


subject: UMLS:C5848866


subject: CHEBI:29191

subject_name: hydroxyl

object_name: osteoporosis


subject: CHEBI:29191

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:29191

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:29191

object_name: Osteoporosis, CTCAE 3.0


subject: UMLS:C0700307

subject_name: hydroxyl group


subject: UMLS:C0700307


subject: UMLS:C0700307


subject: UMLS:C0700307


subject: CHEBI:16234

subject_name: Hydroxide ion


subject: CHEBI:16234


subject: CHEBI:16234


subject: CHEBI:16234


subject: CHEBI:681569

subject_name: Clofarabine

object_name: recurrent childhood acute myeloid leukemia


subject: DRUGBANK:DB05014

object_name: non-small cell lung carcinoma


subject: CHEBI:49956

subject_name: Xenon

object_name: Lung transplant rejection


subject: UNII:XAN4V337CI

subject_name: Aspirin lysine

object_name: Critical Illness


subject: CHEBI:49956


subject: UNII:ZLW14X2D30

object_name: Immune Tolerance


subject: UNII:ZLW14X2D30

object_name: Kidney transplant failure and rejection


subject: UNII:ZLW14X2D30

object_name: chronic kidney disease


subject: UNII:ZLW14X2D30

object_name: end stage renal failure


subject: UNII:ZLW14X2D30

object_name: Chronic uremia


subject: UMLS:C0108779

subject_name: CD3 Antigens


subject: UMLS:C0108779


subject: UMLS:C0108779


subject: UMLS:C0108779


subject: UMLS:C0108779


subject: UNII:834YJF89WO

subject_name: Belumosudil


subject: UNII:834YJF89WO


subject: UNII:834YJF89WO


subject: UNII:834YJF89WO


subject: UNII:834YJF89WO


subject: MESH:C575718

object_name: pancreatic neoplasm


subject: MESH:C575718

object_name: exocrine pancreatic carcinoma


subject: MESH:C575718

object_name: malignant pancreatic neoplasm


subject: UMLS:C3274907


subject: UMLS:C3274907


subject: UMLS:C3274907


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Cannabis use disorder


subject: PUBCHEM.COMPOUND:74328238

subject_name: Sotagliflozin

object_name: Hypertrophic cardiomyopathy without obstruction


subject: PUBCHEM.COMPOUND:74328238

object_name: hypertrophic cardiomyopathy


subject: CHEBI:8378

subject_name: Prednisolone

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:8378

object_name: Childhood Hodgkin Lymphoma


subject: UNII:2N4O9L084N

subject_name: Nabilone

object_name: inflammatory bowel disease


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: UMLS:C0919079

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:94807

subject_name: Nitazoxanide

object_name: bronchiolitis


subject: UMLS:C5203530

subject_name: Tranexamic Acid Liquid Injection

object_name: nephrolithiasis


subject: UMLS:C1831903

object_name: pediatric osteosarcoma


subject: UMLS:C1831903

object_name: Osteosarcoma


subject: UMLS:C1831903

object_name: Childhood Neuroblastoma


subject: UMLS:C1831903

object_name: neuroblastoma


subject: UMLS:C1831903

object_name: childhood malignant neoplasm


subject: CHEBI:15627

subject_name: thromboxane A2

object_name: Androgen excess


subject: PUBCHEM.COMPOUND:53481562

subject_name: Gonadotropin-Releasing Hormone

object_name: Agonadism


subject: CHEBI:5520

subject_name: gonadorelin


subject: PR:000008127


subject: UMLS:C0306166

subject_name: Factrel


subject: PUBCHEM.COMPOUND:46926360

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:46926360

object_name: obesity


subject: PUBCHEM.COMPOUND:46926360

object_name: Obesity, CTCAE


subject: UNII:CQ4M18RLJW


subject: UNII:CQ4M18RLJW


subject: UNII:CQ4M18RLJW


subject: CHEBI:82405

subject_name: Benzoyl peroxide

object_name: molluscum contagiosum


subject: UMLS:C2348288

subject_name: Dietary Zinc

object_name: Wilson disease


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:27363

subject_name: Zinc


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: UMLS:C5907884

subject_name: ConvitVax

object_name: Carcinoma breast stage IV


subject: UNII:7DR7JMB8BH

object_name: melanoma


subject: UNII:SMA5ZS5B22

subject_name: Ensartinib


subject: UMLS:C4763760

subject_name: Gallium Ga 68 NODAGA-CBP8

object_name: Radiation Fibrosis


subject: UMLS:C4763760

object_name: radiation pneumonitis


subject: UMLS:C4763760

object_name: pancreatic neoplasm


subject: UMLS:C4763760

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4763760

object_name: malignant pancreatic neoplasm


subject: CHEBI:60654

subject_name: valproate

object_name: subarachnoid hemorrhage


subject: CHEBI:168243

subject_name: Valproic acid glucuronide


subject: CHEBI:39867

subject_name: Valproic acid


subject: UMLS:C5203017

subject_name: G-Series Nerve Agent GB

object_name: diarrhea


subject: UMLS:C5203017

object_name: rectal discharge diarrhea (physical finding)


subject: UMLS:C5203017

object_name: Diarrhea, CTCAE


subject: UMLS:C5203017

object_name: Rotavirus infection


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Adult Synovial Sarcoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Stage IV adult soft tissue sarcoma


subject: PUBCHEM.COMPOUND:70789204

object_name: stage III adult soft tissue sarcoma


subject: CHEBI:45783

subject_name: Imatinib


subject: CHEBI:45783


subject: UNII:2U3W3584R6

subject_name: LACTOBACILLUS PARACASEI B21060

object_name: inherited lipid metabolism disorder


subject: UNII:2U3W3584R6

object_name: Dyslipidemia


subject: UNII:2U3W3584R6

object_name: hypercholesterolemia, familial, 1


subject: UNII:2U3W3584R6

object_name: familial hypercholesterolemia


subject: CHEBI:7563

subject_name: N-nicotinoylglycine

object_name: hypoalphalipoproteinemia


subject: CHEBI:7563

object_name: coronary artery disorder


subject: CHEBI:7563

object_name: coronary atherosclerosis


subject: MESH:D009539

subject_name: Nicotinic Acids


subject: MESH:D009539


subject: MESH:D009539


subject: UMLS:C3714626

subject_name: Nicotinic Acid Drug Class


subject: UMLS:C3714626


subject: UMLS:C3714626


subject: UMLS:C3536880

subject_name: Nicotinic Acid [EPC]


subject: UMLS:C3536880


subject: UMLS:C3536880


subject: UNII:B2K5L1L8S9

subject_name: Surufatinib

object_name: pancreatic neuroendocrine tumor


subject: UNII:B2K5L1L8S9

object_name: Neuroendocrine tumor of pancreas


subject: UMLS:C5237229

subject_name: Neoantigen Peptide Vaccine

object_name: pancreatic neoplasm


subject: UMLS:C5237229

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5237229

object_name: malignant pancreatic neoplasm


subject: CHEBI:84507

subject_name: Chantix

object_name: inherited disease susceptibility


subject: PUBCHEM.COMPOUND:53486179

subject_name: VARENICLINE TARTRATE


subject: CHEBI:84500

subject_name: varenicline


subject: CHEBI:3219

subject_name: Bupropion


subject: UMLS:C5854382

subject_name: Anti-PD-1/LAG-3 Bispecific Antibody AK129

object_name: colorectal adenocarcinoma


subject: CHEBI:4672

subject_name: Docetaxel


subject: UMLS:C1454298

subject_name: HKI 272

object_name: Childhood Breast Carcinoma


subject: UMLS:C1454298

object_name: breast carcinoma


subject: UMLS:C1454298

object_name: breast cancer


subject: UNII:N5UK68MGDZ

subject_name: Apremilast

object_name: Acne Conglobata


subject: PUBCHEM.COMPOUND:16681698

subject_name: Obatoclax mesylate

object_name: myelofibrosis


subject: CHEBI:94522


subject: UNII:39200FJ43J

subject_name: [OBSOLETE] obatoclax mesylate


subject: UMLS:C1831948

subject_name: obatoclax mesylate


subject: UMLS:C1831949


subject: CHEBI:151315

subject_name: Heparin

object_name: gastroesophageal cancer


subject: CHEBI:151315

object_name: Stomach cancer


subject: CHEBI:151315

object_name: gastric cancer


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:E47C0NF7LV


subject: UNII:E47C0NF7LV


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: UNII:8NZ41MIK1O


subject: UNII:8NZ41MIK1O


subject: UMLS:C2346800

subject_name: TRU 016

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C2346800

object_name: non-Hodgkin lymphoma


subject: UMLS:C5557596

subject_name: Myc Inhibitor OMO-103

object_name: colorectal cancer


subject: UMLS:C5557596

object_name: colorectal carcinoma


subject: UMLS:C5557596

object_name: pancreatic neoplasm


subject: UMLS:C5557596

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5557596

object_name: malignant pancreatic neoplasm


subject: UMLS:C5667029

subject_name: EGFR Mutant-selective Inhibitor BLU-701

object_name: non-small cell lung carcinoma


subject: UMLS:C5667029

object_name: Epidermal growth factor receptor positive non-small cell lung cancer


subject: UMLS:C5667029


subject: UMLS:C5667029

object_name: Activating EGFR Gene Mutation


subject: UMLS:C5667029

object_name: EGFR-TKI Resistant Mutation


subject: UMLS:C5667029

object_name: EGFR gene mutation


subject: UMLS:C5667029

object_name: EGFR exon 19 deletion


subject: UMLS:C5667029

object_name: Neoplasms by Histologic Type


subject: UMLS:C5667029

object_name: respiratory tract neoplasm


subject: UMLS:C5667029

object_name: respiratory system disorder


subject: UMLS:C5667029

object_name: lung cancer


subject: UMLS:C5667029

object_name: lung neoplasm


subject: UMLS:C5667029

object_name: lung disorder


subject: UMLS:C5667029

object_name: bronchogenic carcinoma


subject: UMLS:C5667029

object_name: nervous system cancer


subject: UMLS:C5667029

object_name: bronchial neoplasm


subject: UMLS:C5667029

object_name: neoplasm of thorax


subject: UMLS:C5667029

object_name: cancer


subject: UMLS:C5667029

object_name: esophageal adenocarcinoma


subject: UMLS:C5667029

object_name: lung adenocarcinoma


subject: UMLS:C5667029

object_name: cervical adenocarcinoma


subject: UMLS:C5667029

object_name: adenocarcinoma


subject: UMLS:C5667029

object_name: bile duct adenocarcinoma


subject: UMLS:C5667029

object_name: gastric adenocarcinoma


subject: UMLS:C5667029

object_name: neoplasm


subject: UMLS:C5667029

object_name: carcinoma


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355

object_name: EGFR-TKI Resistant Mutation


subject: CHEBI:31355

object_name: EGFR exon 19 deletion


subject: CHEBI:31355


subject: CHEBI:90943

subject_name: Osimertinib


subject: CHEBI:90943


subject: CHEBI:90943


subject: CHEBI:90943

object_name: Neoplasms by Histologic Type


subject: CHEBI:90943

object_name: respiratory tract neoplasm


subject: CHEBI:90943

object_name: respiratory system disorder


subject: CHEBI:90943

object_name: lung disorder


subject: CHEBI:90943

object_name: bronchogenic carcinoma


subject: CHEBI:90943

object_name: nervous system cancer


subject: CHEBI:90943

object_name: bronchial neoplasm


subject: CHEBI:90943

object_name: neoplasm of thorax


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:167309

subject_name: Methadone

object_name: Caesarean section


subject: UMLS:C0086333

subject_name: Gammagard

object_name: Disseminated neuroblastoma


subject: UMLS:C0086333

object_name: Stage 4S neuroblastoma


subject: UMLS:C0086333

object_name: Regional Neuroblastoma


subject: UMLS:C0086333

object_name: Localized Resectable Neuroblastoma


subject: UMLS:C0086333

object_name: Localized Unresectable Neuroblastoma


subject: CHEBI:44926

subject_name: ubinon

object_name: Pelvis fracture


subject: CHEBI:44926

object_name: Hip Fracture, CTCAE


subject: CHEBI:44926

object_name: hip fracture


subject: CHEBI:44926

object_name: Blood Loss


subject: CHEBI:44926

object_name: Hemorrhage


subject: CHEBI:45716

subject_name: Vorinostat

object_name: laryngeal squamous cell carcinoma


subject: CHEBI:45716

object_name: oropharynx squamous cell carcinoma


subject: CHEBI:45716

object_name: hypopharynx squamous cell carcinoma


subject: CHEBI:45716

object_name: oral cavity squamous cell carcinoma


subject: CHEBI:45716

object_name: human papillomavirus-related squamous cell carcinoma


subject: CHEBI:78825

subject_name: Avutometinib

object_name: thyroid tumor


subject: CHEBI:78825

object_name: thyroid gland carcinoma


subject: CHEBI:78825

object_name: thyroid cancer


subject: UNII:53O87HA2QU

subject_name: Defactinib


subject: UNII:53O87HA2QU


subject: UNII:XDE2GOF1JT

subject_name: LUVELTAMAB TAZEVIBULIN

object_name: lung cancer


subject: UNII:XDE2GOF1JT

object_name: lung neoplasm


subject: UNII:XDE2GOF1JT

object_name: lung carcinoma


subject: UNII:XDE2GOF1JT

object_name: Secondary malignant neoplasm of lung


subject: UNII:XDE2GOF1JT

object_name: non-small cell lung carcinoma


subject: UNII:XDE2GOF1JT

object_name: Metastatic non-small cell lung cancer


subject: UNII:XDE2GOF1JT

object_name: Non-small cell lung cancer stage IIIB


subject: UMLS:C4764024

subject_name: Anti-FolRa ADC STRO-002


subject: UMLS:C4764024


subject: UMLS:C4764024


subject: UMLS:C4764024


subject: UMLS:C4764024


subject: UMLS:C4764024


subject: UMLS:C4764024


subject: CHEBI:35915

subject_name: sterol ester

object_name: Hypercholesterolemia


subject: UMLS:C0597522


subject: UNII:DW4WDF59AP

subject_name: ALCOHOL 50%

object_name: osteoarthritis, knee


subject: UMLS:C2351194

object_name: interstitial lung disease 1


subject: UMLS:C2351194

object_name: interstitial lung disease 2


subject: UMLS:C2351194

object_name: pulmonary fibrosis


subject: UMLS:C2351194

object_name: idiopathic interstitial pneumonia


subject: PUBCHEM.COMPOUND:54760385

object_name: acute myeloid leukemia by FAB classification


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: EGFR gene mutation


subject: CHEBI:114785

subject_name: Erlotinib


subject: UNII:K5CXA4X5U8

subject_name: relmacabtagene autoleucel

object_name: high grade B-cell lymphoma


subject: UNII:K5CXA4X5U8

object_name: grade 3B follicular lymphoma


subject: UNII:K5CXA4X5U8

object_name: primary mediastinal large B-cell lymphoma


subject: UMLS:C0108170

subject_name: calin

object_name: Menopause present (finding)


subject: UMLS:C0108170

object_name: Menopause


subject: UMLS:C0108170

object_name: vitamin D deficiency


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: core binding factor acute myeloid leukemia


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: UMLS:C4087034

subject_name: Spleen Tyrosine Kinase Inhibitor HMPL-523

object_name: autoimmune hemolytic anemia, warm type


subject: CHEBI:35679

subject_name: antilipemic drug

object_name: Adverse effects


subject: UNII:99A996378Y

object_name: HIV infection


subject: CHEBI:146178

subject_name: RACEMETHORPHAN

object_name: cognitive disorder


subject: CHEBI:146178

object_name: Cognitive impairment


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:146176


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:4470


subject: UNII:U59UGK3IPC

subject_name: Ublituximab

object_name: B-cell non-Hodgkin lymphoma


subject: UNII:U59UGK3IPC

object_name: primary central nervous system lymphoma


subject: UMLS:C2934225


subject: UMLS:C2934225


subject: UMLS:C5206815

object_name: Childhood Solid Neoplasm


subject: UMLS:C5206815

object_name: Adult Solid Neoplasm


subject: UMLS:C3273249

subject_name: Topical Wound Spray HP802-247

object_name: ulcer disease


subject: UMLS:C3273249

object_name: Venous stasis ulcer of leg


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Ischemic stroke


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Acute abdomen


subject: UMLS:C0445115

subject_name: Normal saline

object_name: appendicitis


subject: UMLS:C0445115

object_name: Appendicitis, CTCAE


subject: UMLS:C0445115

object_name: Abdominal pain


subject: UMLS:C0445115

object_name: Abdominal Pain, CTCAE


subject: UMLS:C0445115


subject: CHEBI:85993

subject_name: Palbociclib

object_name: Mantle cell lymphoma recurrent


subject: UNII:53T7IN77LC

subject_name: Fialuridine

object_name: hepatitis B


subject: UNII:53T7IN77LC

object_name: herpes simplex


subject: UNII:53T7IN77LC

object_name: HIV infection


subject: CHEBI:3127

subject_name: Bisoprolol

object_name: Hypertension resistant to conventional therapy


subject: CHEBI:4708

subject_name: Doxazosin


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: Metastatic Microsatellite Stable Colorectal Carcinoma


subject: CHEBI:233362

object_name: Refractory Microsatellite Stable Colorectal Carcinoma


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: CHEBI:46345

subject_name: Fluorouracil


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: thrombocytopenia


subject: CHEBI:72564

subject_name: Temozolomide


subject: UNII:21K6M2I7AG

subject_name: interferon gamma-1b

object_name: Carcinoma of peritoneum


subject: UNII:21K6M2I7AG

object_name: peritoneal carcinoma


subject: UNII:21K6M2I7AG

object_name: ovarian cancer


subject: UNII:21K6M2I7AG

object_name: ovarian carcinoma


subject: UNII:21K6M2I7AG

object_name: malignant epithelial tumor of ovary


subject: UMLS:C0021741

subject_name: Actimmune


subject: UMLS:C0021741


subject: UMLS:C0021741


subject: UNII:W0ZE0NT8IF

subject_name: Etrumadenant

object_name: pancreatic ductal adenocarcinoma


subject: UNII:J6K8WSV73A

subject_name: Quemliclustat


subject: UMLS:C1879771

subject_name: BIBF 1120

object_name: Childhood Breast Carcinoma


subject: UMLS:C1879771

object_name: breast carcinoma


subject: UMLS:C1879771

object_name: breast cancer


subject: CHEBI:135901

subject_name: lanreotide

object_name: endocrine exophthalmos


subject: UMLS:C0051846

subject_name: angiopeptin


subject: UMLS:C3274747

subject_name: SR-T100 Gel

object_name: Condylomata acuminata in women


subject: UMLS:C3274747

object_name: Condylomata acuminata in men


subject: CHEBI:144094

subject_name: bicalutamide

object_name: superficial urinary bladder carcinoma


subject: CHEBI:73024

subject_name: O-acetylcarnitine

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: CHEBI:57589

subject_name: Acetylcarnitine


subject: UMLS:C3827186

subject_name: Jobelyn

object_name: hematologic disorder


subject: UMLS:C1704263

subject_name: green tea extract

object_name: lung cancer


subject: UMLS:C1704263

object_name: lung neoplasm


subject: UMLS:C1704263

object_name: lung carcinoma


subject: UMLS:C1704263

object_name: carcinoma of esophagus


subject: UMLS:C1704263

object_name: esophageal cancer


subject: UMLS:C1704263

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C1704263

object_name: neoplasm of esophagus


subject: UMLS:C1704263

object_name: Stomach cancer


subject: UMLS:C1704263

object_name: gastric cancer


subject: DRUGBANK:DB14307

subject_name: Green tea leaf


subject: DRUGBANK:DB14307


subject: DRUGBANK:DB14307